PA
ISRG icon

PharVision Advisers’s Intuitive Surgical ISRG Stock Holding History

PharVision Advisers’s Portfolio ISRG Stock Details ISRG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-531
Closed -$237K – 844
2025
Q3 		$237K Buy
+531
New +$255K 0.13% 370
2025
Q1 		– Sell
-1,296
Closed -$676K – 394
2024
Q4 		$676K Buy
+1,296
New +$675K 0.57% 20

Other funds holding ISRG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

PharVision Advisers's ISRG Position: Q4 2025 in Review

PharVision Advisers sold out of Intuitive Surgical (ISRG) in Q4 2025, closing a stake of 531 shares — an estimated $237K sold.

PharVision Advisers first reported a position in ISRG in Q4 2024 and held it in 2 quarters. The position peaked at $676K in Q4 2024. 2,412 funds tracked by Wall St. Rank hold ISRG as of Q4 2025.

  • PharVision Advisers reported no remaining Intuitive Surgical position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 531 Intuitive Surgical shares in Q4 2025, an estimated $237K.
  • PharVision Advisers first reported a position in Intuitive Surgical in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Intuitive Surgical position peaked at $676K in Q4 2024.
  • 2,412 funds tracked by Wall St. Rank held Intuitive Surgical as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.